A 70-year-old white man with stage C chronic lymphocytic leukemia who was being successfully treated with ibrutinib and rituximab developed bilateral, purpuric, painful cutaneous nodules. Biopsies of these nodules did not reveal the usual Th2 milieu of chronic lymphocytic leukemia but instead exhibited a Th1-rich lymphocytic infiltrate with resultant neutrophil and granulomatous inflammation. The eruption resolved with drug cessation emphasizing the potential importance of this drug in treating conditions associated with Th2 dysregulation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/DAD.0000000000000441 | DOI Listing |
Cureus
November 2024
Rheumatology, University Hospital of North Durham, Durham, GBR.
A male patient in his 30s with autism and depression presented to the emergency department with joint pain, a petechial/purpuric rash, sputum production, hemoptysis, and epistaxis. His mother reported a family history of autoimmune conditions. Examination revealed a non-blanching petechial/purpuric rash and tenderness in the feet and ankles.
View Article and Find Full Text PDFCureus
August 2024
Internal Medicine, Unidade Local de Saúde Viseu Dão-Lafões, Viseu, PRT.
Cureus
August 2024
Internal Medicine Department, Unidade Local de Saúde de São João, Porto, PRT.
Cureus
August 2024
Internal Medicine, Mamata Academy of Medical Sciences, Hyderabad, IND.
HCA Healthc J Med
August 2024
Menorah Medical Center, Overland Park, KS.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!